Auriga USA initiates coverage of Genoptix (Nasdaq: GXDX) with a Buy rating and a $34 price target.

Auriga ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE